These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17053468)

  • 1. Dyslipidemia, inflammation and dialysis outcomes: what we know now.
    Krane V; Drechsler C; Wanner C
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):566-70. PubMed ID: 17053468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.
    Wanner C; Drechsler C; Krane V
    J Ren Nutr; 2007 Jan; 17(1):75-8. PubMed ID: 17198938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dyslipidemia of chronic renal disease: effects of statin therapy.
    Ozsoy RC; van Leuven SI; Kastelein JJ; Arisz L; Koopman MG
    Curr Opin Lipidol; 2006 Dec; 17(6):659-66. PubMed ID: 17095911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statins in chronic renal disease].
    Ferreira SR; Rocha AM; Saraiva JF
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing dyslipidemia in chronic kidney disease.
    Harper CR; Jacobson TA
    J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of statins on renal function.
    Agarwal R
    Am J Cardiol; 2006 Mar; 97(5):748-55. PubMed ID: 16490450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of cardiovascular risk in hemodialysis patients: an evidence-based review.
    Johnson DW; Craven AM; Isbel NM
    Hemodial Int; 2007 Jan; 11(1):1-14. PubMed ID: 17257349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
    Scarpioni R; Ricardi M; Melfa L; Cristinelli L
    Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked].
    Efendic E; Lindholm B; Bergström J; Stenvinkel P
    Lakartidningen; 1999 Oct; 96(42):4538-42. PubMed ID: 10575860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid abnormalities and cardiovascular risk in renal disease.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2008 Jun; 19(6):1065-70. PubMed ID: 18369085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholesterol paradox is flawed; cholesterol must be lowered in dialysis patients.
    Wan RK; Mark PB; Jardine AG
    Semin Dial; 2007; 20(6):504-9. PubMed ID: 17991195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular death in dialysis patients: lessons we can learn from AURORA.
    Sniderman AD; Solhpour A; Alam A; Williams K; Sloand JA
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):335-40. PubMed ID: 20056762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
    Wanner C; Zimmermann J; Quaschning T; Galle J
    Kidney Int Suppl; 1997 Nov; 62():S53-5. PubMed ID: 9350681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.